Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4801)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2014 (publication date) through May 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lam MC, Lee T, Atkinson K, Bressler B. Time of infliximab therapy initiation and dose escalation in Crohn’s disease. World J Gastroenterol 2014; 20(1): 214-218 [PMID: 24415874 DOI: 10.3748/wjg.v20.i1.214] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i1/214.htm |
| Number | Citing Articles |
| 1 |
Laura Guberna, Olga P. Nyssen, María Chaparro, Javier P. Gisbert. Frequency and Effectiveness of Empirical Anti-TNF Dose Intensification in Inflammatory Bowel Disease: Systematic Review with Meta-Analysis. Journal of Clinical Medicine 2021; 10(10): 2132 doi: 10.3390/jcm10102132
|
| 2 |
Ronen Stein, Dale Lee, Mary B. Leonard, Meena Thayu, Lee A. Denson, Emil Chuang, Rita Herskovitz, Theresa Kerbowski, Robert N. Baldassano. Serum Infliximab, Antidrug Antibodies, and Tumor Necrosis Factor Predict Sustained Response in Pediatric Crohnʼs Disease. Inflammatory Bowel Diseases 2016; 22(6): 1370 doi: 10.1097/MIB.0000000000000769
|
| 3 |
Laura E. Targownik, Aruni Tennakoon, Stella Leung, Lisa M. Lix, Zoann Nugent, Harminder Singh, Charles N. Bernstein. Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD. Inflammatory Bowel Diseases 2017; 23(3): 409 doi: 10.1097/MIB.0000000000001025
|
| 4 |
Neasa Mc Gettigan, Aine Keogh, Orla McCarthy, Mairead McNally, Charlene Deane, Eoin Slattery. The effects of proactive therapeutic drug monitoring vs reactive therapeutic drug monitoring in a virtual biologic clinic, a retrospective cohort study. GastroHep 2019; 1(6): 274 doi: 10.1002/ygh2.373
|
| 5 |
Yun Qiu, Bai-li Chen, Ren Mao, Sheng-hong Zhang, Yao He, Zhi-rong Zeng, Shomron Ben-Horin, Min-hu Chen. Systematic review with meta-analysis: loss of response and requirement of anti-TNFα dose intensification in Crohn’s disease. Journal of Gastroenterology 2017; 52(5): 535 doi: 10.1007/s00535-017-1324-3
|